Company establishes U.S. governance standards with appointment of new directors and sub-committees
MINNEAPOLIS, May 16, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo Health” or the “Company”) (CSE: VREO), a leading science-focused, multi-state cannabis company, today announced the addition of four new Directors to the Company’s Board and the formation of three committees to provide oversight and guidance on Audit, Compensation, and other Corporate Governance matters.
Vireo Health is pleased to have added several highly-regarded industry leaders with deep retail, manufacturing and financial expertise to help guide the Company as we continue to execute upon our ambitious growth plans.
Kyle Kingsley, M.D., Chief Executive Officer
Together with our extremely talented leadership team and dedicated workforce, I am confident we have the necessary